These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 24717259)

  • 1. Ramelteon monotherapy for insomnia and impulsive behavior in high-functioning autistic disorder.
    Asano M; Ishitobi M; Kosaka H; Hiratani M; Wada Y
    J Clin Psychopharmacol; 2014 Jun; 34(3):402-3. PubMed ID: 24717259
    [No Abstract]   [Full Text] [Related]  

  • 2. Ramelteon for insomnia in two youths with autistic disorder.
    Stigler KA; Posey DJ; McDougle CJ
    J Child Adolesc Psychopharmacol; 2006 Oct; 16(5):631-6. PubMed ID: 17069551
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A new strategy of treatment of insomnia in the field of cardiology--potential of ramelteon].
    Hiromasa S
    Nihon Rinsho; 2013 Jan; 71(1):181-7. PubMed ID: 23631192
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ramelteon for the treatment of insomnia.
    Borja NL; Daniel KL
    Clin Ther; 2006 Oct; 28(10):1540-55. PubMed ID: 17157111
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of ramelteon in Japanese adults with chronic insomnia: a randomized, double-blind, placebo-controlled study.
    Uchimura N; Ogawa A; Hamamura M; Hashimoto T; Nagata H; Uchiyama M
    Expert Rev Neurother; 2011 Feb; 11(2):215-24. PubMed ID: 21306209
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ramelteon (Rozerem) for insomnia.
    Med Lett Drugs Ther; 2005 Nov; 47(1221):89-91. PubMed ID: 16267494
    [No Abstract]   [Full Text] [Related]  

  • 7. Effects of ramelteon on patient-reported sleep latency in older adults with chronic insomnia.
    Roth T; Seiden D; Sainati S; Wang-Weigand S; Zhang J; Zee P
    Sleep Med; 2006 Jun; 7(4):312-8. PubMed ID: 16709464
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ramelteon: application withdrawn. Ramelteon in insomnia: withdrawal of marketing application in patients' best interests.
    Prescrire Int; 2009 Jun; 18(101):114. PubMed ID: 19639675
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of a post-sleep questionnaire-interactive voice response system (PSQ-IVRS) to evaluate the subjective sleep effects of ramelteon in adults with chronic insomnia.
    Wang-Weigand S; Watissée M; Roth T
    Sleep Med; 2011 Oct; 12(9):920-3. PubMed ID: 21925941
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Delirium, insomnia in hospitalization and ramelteon].
    Ito T
    Nihon Rinsho; 2012 May; 70(5):907-13. PubMed ID: 22620020
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ramelteon: a novel approach in the treatment of insomnia.
    Reynoldson JN; Elliott E; Nelson LA
    Ann Pharmacother; 2008 Sep; 42(9):1262-71. PubMed ID: 18648020
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [New hypnotics ramelteon for the treatment of insomniacs with circadian rhythm disturbance].
    Mishima K
    Nihon Rinsho; 2012 Jun; 70(6):1069-78. PubMed ID: 22690618
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomized, placebo-controlled study of adjunctive ramelteon in ambulatory bipolar I disorder with manic symptoms and sleep disturbance.
    McElroy SL; Winstanley EL; Martens B; Patel NC; Mori N; Moeller D; McCoy J; Keck PE
    Int Clin Psychopharmacol; 2011 Jan; 26(1):48-53. PubMed ID: 20861739
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A novel therapeutic drug: ramelteon].
    Miyamoto M
    Nihon Rinsho; 2009 Aug; 67(8):1595-600. PubMed ID: 19768947
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ramelteon: new drug. Insomnia: no role for risky placebos.
    Prescrire Int; 2008 Oct; 17(97):183-6. PubMed ID: 19534018
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ramelteon and improved insomnia in alcohol-dependent patients: a case series.
    Brower KJ; Conroy DA; Kurth ME; Anderson BJ; Stein MD
    J Clin Sleep Med; 2011 Jun; 7(3):274-5. PubMed ID: 21677897
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug Insight: the use of melatonergic agonists for the treatment of insomnia-focus on ramelteon.
    Pandi-Perumal SR; Srinivasan V; Poeggeler B; Hardeland R; Cardinali DP
    Nat Clin Pract Neurol; 2007 Apr; 3(4):221-8. PubMed ID: 17410109
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Self-reported efficacy and tolerability of ramelteon 8 mg in older adults experiencing severe sleep-onset difficulty.
    Mini LJ; Wang-Weigand S; Zhang J
    Am J Geriatr Pharmacother; 2007 Sep; 5(3):177-84. PubMed ID: 17996657
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An efficacy, safety, and dose-response study of Ramelteon in patients with chronic primary insomnia.
    Erman M; Seiden D; Zammit G; Sainati S; Zhang J
    Sleep Med; 2006 Jan; 7(1):17-24. PubMed ID: 16309958
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Augmentation with ramelteon to achieve remission in geriatric major depression.
    Furuya M; Kunishige K; Miyaoka T; Wake R; Liaury K; Sadakuni F; Horiguchi J
    Psychiatry Clin Neurosci; 2012 Feb; 66(1):81-2. PubMed ID: 22250616
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.